Comprehensive Health Science Center, Aichi Health Promotion Public Interest Foundation.
University at Albany (SUNY) School of Public Health.
J Atheroscler Thromb. 2018 Apr 1;25(4):308-322. doi: 10.5551/jat.42010. Epub 2017 Dec 12.
All health insurers in Japan are mandated to provide Specific Health Checkups and Specific Health Guidance (SHG) focusing on metabolic syndrome (MetS) in middle-aged adults, beginning in 2008; intensive HG for individuals who have abdominal obesity and two or more additional MetS risk factors, and motivational HG for individuals with one risk factor. The aim of this study is to describe medium-term changes in health indexes for intensive and motivational HG groups using the National Database.
We compared changes of risk factors and initiation of pharmacological therapy over 3 yr between participants (n=31,790) and nonparticipants (n=189,726) who were eligible for SHG in 2008.
Body weight reduction in intensive HG was 1.98 kg (participants) vs 0.42 kg (nonparticipants) in men (p<0.01) and 2.25 vs 0.68 kg in women (p<0.01) after 1 yr. In motivational HG, the respective reduction was 1.40 vs 0.30 kg in men (p<0.01) and 1.53 vs 0.42 kg in women (p<0.01). Waist circumference reduction was also greatest among participants in intensive HG (2.34 cm in men and 2.98 cm in women). These reductions were fairly unchanged over 3 yr and accompanied greater improvements in MetS risk factors in participants. We also detected significantly smaller percentages of SHG participants who initiated pharmacological therapy compared with nonparticipants.
Participants in SHG showed greater improvements in MetS profiles with proportionally smaller pharmacological treatment initiations than did nonparticipants for 3 yr. Although selection bias may be present, this study suggests SHG would be a feasible strategy to prevent MetS and its sequelae.
自 2008 年起,日本所有的健康保险公司都必须为中年成年人提供特定健康检查和特定健康指导(SHG),重点是代谢综合征(MetS);针对有腹部肥胖和两个或更多其他 MetS 风险因素的个体进行强化 HG,以及针对有一个风险因素的个体进行激励性 HG。本研究的目的是使用国家数据库描述强化和激励性 HG 组的健康指标的中期变化。
我们比较了 2008 年有资格接受 SHG 的参与者(n=31790)和非参与者(n=189726)在 3 年内风险因素的变化和药物治疗的开始情况。
强化 HG 中男性体重减轻 1.98 公斤(参与者)比非参与者 0.42 公斤(非参与者)(p<0.01),女性体重减轻 2.25 公斤比非参与者 0.68 公斤(p<0.01)。在激励性 HG 中,男性分别减少 1.40 公斤比非参与者 0.30 公斤(p<0.01),女性分别减少 1.53 公斤比非参与者 0.42 公斤(p<0.01)。在强化 HG 中,腰围减少也最大(男性 2.34 厘米,女性 2.98 厘米)。这些减少在 3 年内基本不变,并伴随着参与者中 MetS 风险因素的更大改善。我们还发现,与非参与者相比,SHG 参与者开始药物治疗的比例明显较小。
与非参与者相比,SHG 参与者在 3 年内对 MetS 特征的改善更大,药物治疗的开始比例更小。尽管可能存在选择偏倚,但这项研究表明 SHG 是预防 MetS 及其后果的一种可行策略。